The terms for the following active ingredients were extended due to delays in processing the applications for evaluation and approval renewal at the EU Commission.
Active Ingredients |
Limited until |
Reference |
Chlortoluron, Clomazone, Cypermethrin, Daminozide, Deltamethrin, Fludioxonil, Flufenacet, Fosthiazate, Indoxacarb, MCPA, MCPB, Prosulfocarb, |
10/31/2022 |
Commission Implementing Regulation (EU) 2021/1449 |
Chlormequat, Propaquizafop, Quizalofop-P-ethyl, Quizalofop-P-tefuryl Tritosulfuron, |
11/30/2022 |
|
2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, Amidosulfuron, Bifenox, Clofentezine, Dicamba, Difenoconazole, Diflufenican, Dimethachlor, Etofenprox, Fenoxaprop-P, Fenpropidin, Lenacil, Nicosulfuron, Paraffinöle, Paraffinöl, Picloram, Penconazole, , Schwefel, Tetraconazole, Tri-allate, Triflusulfuron |
12/31/2022 |
The lifetime extensions do not affect the current MRLs and may be withdrawn at any time if an active substance is refused re-approval under the approval process.
Author: Dr. Frank Mörsberger